Porphyria cutanea tarda in the setting of renal failure. Response to renal transplantation

1993 ◽  
Vol 129 (3) ◽  
pp. 337-339 ◽  
Author(s):  
B. R. Stevens
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Porphyria Cutanea Tarda

Overview of blood purification in uremia

1980 ◽  
Vol 3 (4) ◽  
pp. 203-208
Author(s):  
B.T. Burton
Keyword(s):  
Renal Failure ◽  
Peritoneal Dialysis ◽  
Renal Transplantation ◽  
Rejection Rate ◽  
Blood Purification ◽  
Maintenance Hemodialysis ◽  
Dialysis Patients ◽  
Transplant Patients ◽  
Maintenance Dialysis ◽  
Transplanted Kidneys

Today, management of irreversible renal failure is based primarily on maintenance hemodialysis and renal transplantation with a growing minority of patients treated by peritoneal dialysis. With regard to renal transplantation — the early promise of renal transplantation in the mid 1960's has given way to the realities of the late 1970's. There have been no major changes in the rejection rate of transplanted kidneys in recent years though today's mortality of transplant patients is considerably reduced over what it used to be. Moreover, universally the lack of availability of a sufficient number of organs for transplantation poses a formidable problem. It is all too apparent that current methods of blood purification in uremia are far from optimal. Even though the mortality in maintenance dialysis is relatively low, hemodialysis is characterized by a variety of complications and most maintenance dialysis patients are not optimally rehabilitated.

A Case of Living-Donor Renal Transplantation for Chronic Renal Failure Caused by Secondary Amyloidosis

2011 ◽  
Vol 43 (6) ◽  
pp. 2418-2420 ◽  
Author(s):  
K. Sakai ◽  
M. Okamoto ◽  
K. Koshino ◽  
T. Suzuki ◽  
S. Nobori ◽  
...  
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Chronic Renal Failure ◽  
Living Donor ◽  
Secondary Amyloidosis

Live donor renal transplantation in patients with end-stage renal failure due to IgA nephropathy: clinicopathological assessment

Nephrology ◽  
2002 ◽  
Vol 7 ◽  
pp. S74-S77
Author(s):  
Yu Seun Kim ◽  
Hyeon Joo Jeong ◽  
Kye Won Kwon ◽  
Ho Yung Lee ◽  
Dae Suk Han ◽  
...  
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Iga Nephropathy ◽  
Live Donor ◽  
End Stage Renal Failure ◽  
End Stage

TREATMENT ALTERNATIVES IN RENAL FAILURE AND RENAL TRANSPLANTATION PATIENTS WITH NONOBSTRUCTIVE COLONIC DILATATION

1983 ◽  
Vol 36 (1) ◽  
pp. 37-39 ◽  
Author(s):  
WILLIAM E. STRODEL ◽  
THOMAS L. DENT ◽  
TIMOTHY T. NOSTRANT ◽  
FREDERIC E. ECKHAUSER ◽  
DARRELL A. CAMPBELL ◽  
...  
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Treatment Alternatives

Renal transplantation in the first year of life: the treatment of choice for infants with end-stage renal disease.

1992 ◽  
Vol 2 (12) ◽  
pp. S228
Author(s):  
J S Najarian ◽  
P S Almond ◽  
M Mauer ◽  
B Chavers ◽  
T Nevins ◽  
...  
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Survival Rate ◽  
Living Donor ◽  
Patient Survival ◽  
First Year ◽  
End Stage Renal Failure ◽  
End Stage ◽  
First Year Of Life ◽  
Patient Survival Rate

The treatment of choice for end-stage renal failure within the first year of life is controversial. Between September 1970 and February 1991, we performed 28 kidney transplants (27 primary, 1 retransplant, 23 living donor, 5 cadaver) in infants less than 1 yr of age (mean, 7 +/- 2 months; range, 6 wk to 12 months). The 1-yr patient survival rate for living donor recipients was 100% versus 20% for cadaver recipients (P = 0.0001). The 1-yr graft survival rate for living donor recipients was 96% versus 20% for cadaver recipients (P = 0.001). The 1-yr patient survival rate for cyclosporin A (CSA) recipients (N = 12) was 100% versus 75% for non-CSA recipients (P = 0.03). The 1-yr graft survival rate for CSA recipients was 92% versus 75% for non-CSA recipients (P = 0.08). There was no difference in the number of rejection episodes or serum creatinine levels in CSA versus non-CSA recipients. Compared with pretransplant values, the mean posttransplant standard deviation scores (SDS) for height (N = 18), weight (N = 22), and head circumference (N = 8) improved: height SDS from -1.9 to -1.5 (not significant); weight SDS from -2.5 to 0.6 (P less than 0.0005); head circumference SDS from -2.0 to -0.7 (P = 0.01). Because no other renal replacement therapy can match these results, we conclude that renal transplantation is the treatment of choice for infants with end-stage renal failure.

scholarly journals New-Onset Diabetes After Renal Transplantation (NODAT): Is It a Risk Factor for Renal Cell Carcinoma or Renal Failure?

2019 ◽  
Vol 24 ◽  
pp. 62-69 ◽  
Author(s):  
Haibo Nie ◽  
Wei Wang ◽  
Yongbin Zhao ◽  
Xiaoming Zhang ◽  
Yuansong Xiao ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Renal Failure ◽  
Risk Factor ◽  
Renal Transplantation ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Onset Diabetes ◽  
New Onset

scholarly journals Clam ileoplasty bladder augmentation and renal transplantation

2007 ◽  
Vol 54 (4) ◽  
pp. 79-81
Author(s):  
D. Milutinovic ◽  
C. Topuzovic ◽  
J. Hadzi-Djokic
Keyword(s):  
Renal Failure ◽  
Kidney Transplantation ◽  
Renal Transplantation ◽  
Bladder Augmentation ◽  
Bladder Function ◽  
End Stage Renal Failure ◽  
Clam Ileocystoplasty ◽  
End Stage

In our patient, with a small contacted bladder and end stage renal failure, bladder augmentation (clam ileocystoplasty) was done in conjunction with renal transplantation. Our patient has stable renal and bladder function 46 months after kidney transplantation.

Free radical ablation for the prevention of post-ischemic renal failure following renal transplantation

1991 ◽  
Vol 69 (21-23) ◽  
pp. 1083-1094 ◽  
Author(s):  
H. J. Schiller ◽  
K. A. Andreoni ◽  
G. B. Bulkley
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Free Radical ◽  
Ischemic Renal Failure
Sign in / Sign up

Export Citation Format

Share Document